Andreas H. Diacon

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2009 · 839 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2014 · 752 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

Andreas H. Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier et al. · The Lancet · 2012 · 433 citations

Pharmacy, Microbiology, Pharmacology +14

Phase 2b Controlled Trial of M72/AS01 _E Vaccine to Prevent Tuberculosis

Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba et al. · New England Journal of Medicine · 2018 · 412 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +17

Diagnostic tools in tuberculous pleurisy: a direct comparative study

Andreas H. Diacon, B. W. Van de Wal, C Wyser et al. · European Respiratory Journal · 2003 · 410 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +15